The Washington Post is featuring an article by Tom Shroder adapted from his book Acid Test: LSD, Ecstasy, and the Power to Heal (Blue Rider Press, 2014). Shroder covers the history of psychedelic research from Albert Hoffman’s discovery of LSD in the 1940s to recent work by Heffter researcher Matthew Johnson on the use of psilocybin to treat tobacco addiction. Among other milestones, Shroder notes that some researchers credit the beginning of modern brain science to the discovery that the LSD molecule and the neurotransmitter serotonin are remarkably similar.
“After more than 30 years in which psychedelics were considered dangerous remnants of the 1960s, the drugs have begun to make a comeback, this time as potential remedies for a host of tough-to-treat maladies. Pilot studies and clinical trials of LSD, psilocybin, ketamine and MDMA have shown that the drugs, often in combination with talk therapy, can be given safely under medical supervision and may help people dealing with opiate and tobacco addiction, alcoholism, anxiety, depression, and post-traumatic streass disorder, or PTSD.”